/Companies

RiboGenyX

1 known investors

Find your way into RiboGenyX

Sign up to see every warm intro you have to RiboGenyX

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RiboGenyX team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ribogenyx develops first-in-class therapeutic enhancers of translational fidelity, targeting mRNA translation processes for precision medicine. Its focus is on age-related diseases and mechanisms of stress resilience mediated by mRNA translation.

Founders & leadership

AAngelos
Angelos
MMaxime
MaximeFounder

Investors · 1

Frequently asked questions

What does RiboGenyX do?
Ribogenyx develops first-in-class therapeutic enhancers of translational fidelity, targeting mRNA translation processes for precision medicine. Its focus is on age-related diseases and mechanisms of stress resilience mediated by mRNA translation.
Who founded RiboGenyX?
RiboGenyX was founded by Angelos, Maxime.
Who are RiboGenyX's investors?
RiboGenyX's investors include Fifty Years.